These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36625664)

  • 1. Development of Nanoparticle Adaptation Phenomena in Acinetobacter baumannii: Physiological Change and Defense Response.
    McNeilly O; Mann R; Cummins ML; Djordjevic SP; Hamidian M; Gunawan C
    Microbiol Spectr; 2023 Feb; 11(1):e0285722. PubMed ID: 36625664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heritable nanosilver resistance in priority pathogen: a unique genetic adaptation and comparison with ionic silver and antibiotics.
    Valentin E; Bottomley AL; Chilambi GS; Harry EJ; Amal R; Sotiriou GA; Rice SA; Gunawan C
    Nanoscale; 2020 Jan; 12(4):2384-2392. PubMed ID: 31930233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Concern for Silver Nanoparticle Resistance in
    McNeilly O; Mann R; Hamidian M; Gunawan C
    Front Microbiol; 2021; 12():652863. PubMed ID: 33936010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance.
    Mann R; Holmes A; McNeilly O; Cavaliere R; Sotiriou GA; Rice SA; Gunawan C
    J Nanobiotechnology; 2021 Sep; 19(1):291. PubMed ID: 34579731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silver nanoparticles synthesized with Eucalyptus critriodora ethanol leaf extract stimulate antibacterial activity against clinically multidrug-resistant Acinetobacter baumannii isolated from pneumonia patients.
    Wintachai P; Paosen S; Yupanqui CT; Voravuthikunchai SP
    Microb Pathog; 2019 Jan; 126():245-257. PubMed ID: 30445131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii.
    Hetta HF; Al-Kadmy IMS; Khazaal SS; Abbas S; Suhail A; El-Mokhtar MA; Ellah NHA; Ahmed EA; Abd-Ellatief RB; El-Masry EA; Batiha GE; Elkady AA; Mohamed NA; Algammal AM
    Sci Rep; 2021 May; 11(1):10751. PubMed ID: 34031472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial action of 1,10-phenanthroline-based compounds on carbapenemase-producing Acinetobacter baumannii clinical strains: efficacy against planktonic- and biofilm-growing cells.
    Ventura RF; Galdino ACM; Viganor L; Schuenck RP; Devereux M; McCann M; Santos ALS; Nunes APF
    Braz J Microbiol; 2020 Dec; 51(4):1703-1710. PubMed ID: 32737867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread and Indiscriminate Nanosilver Use: Genuine Potential for Microbial Resistance.
    Gunawan C; Marquis CP; Amal R; Sotiriou GA; Rice SA; Harry EJ
    ACS Nano; 2017 Apr; 11(4):3438-3445. PubMed ID: 28339182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
    Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
    Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiate the activity of current antibiotics by naringin dihydrochalcone targeting the AdeABC efflux pump of multidrug-resistant Acinetobacter baumannii.
    Verma P; Tiwari M; Tiwari V
    Int J Biol Macromol; 2022 Sep; 217():592-605. PubMed ID: 35841965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
    Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
    Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of silver nanoparticles functionalized with amikacin applied against multidrug-resistant acinetobacter baumannii.
    Camargo LO; Fontoura I; Veriato TS; Raniero L; Castilho ML
    Am J Infect Control; 2023 Aug; 51(8):871-878. PubMed ID: 36581226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efflux pump inhibitory activity of biologically synthesized silver nanoparticles against multidrug-resistant Acinetobacter baumannii clinical isolates.
    Behdad R; Pargol M; Mirzaie A; Karizi SZ; Noorbazargan H; Akbarzadeh I
    J Basic Microbiol; 2020 Jun; 60(6):494-507. PubMed ID: 32301139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii.
    Oyejobi GK; Xiong D; Shi M; Zhang X; Yang H; Xue H; Ogolla F; Wei H
    J Bacteriol; 2022 Mar; 204(3):e0059321. PubMed ID: 35156836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothetical adhesin CAM87009.1 formulated in alum or biogenic silver nanoparticles protects mice from lethal infection by multidrug-resistant Acinetobacter baumannii.
    Buchhorn de Freitas S; Clair Pinto Seixas Neto A; Aparecido Panagio L; Pereira Soares M; Drawanz Hartwig D
    Vaccine; 2024 Jul; 42(18):3802-3810. PubMed ID: 38719690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethyl chitosan-capped silver nanoparticles with positive surface charge: Their catalytic activity and antibacterial spectrum including multidrug-resistant strains of Acinetobacter baumannii.
    Chang TY; Chen CC; Cheng KM; Chin CY; Chen YH; Chen XA; Sun JR; Young JJ; Chiueh TS
    Colloids Surf B Biointerfaces; 2017 Jul; 155():61-70. PubMed ID: 28411476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial Activities of Bacteriagenic Silver Nanoparticles Against Nosocomial
    Singh R; Vora J; Nadhe SB; Wadhwani SA; Shedbalkar UU; Chopade BA
    J Nanosci Nanotechnol; 2018 Jun; 18(6):3806-3815. PubMed ID: 29442713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction.
    Kong D; Hua X; Zhou R; Cui J; Wang T; Kong F; You H; Liu X; Adu-Amankwaah J; Guo G; Zheng K; Wu J; Tang R
    Microbiol Spectr; 2022 Oct; 10(5):e0131222. PubMed ID: 36190276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy of Imipenem Conjugated with Synthesized Silver Nanoparticles Against Acinetobacter baumannii Clinical Isolates, Iran.
    Zendegani E; Dolatabadi S
    Biol Trace Elem Res; 2020 Sep; 197(1):330-340. PubMed ID: 31701463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.